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Introduction
Total hip arthroplasty (THA)1 is offered to patients with end-
stage hip osteoarthritis to reduce pain and improve function1. 
Muscle strength and functional performance, such as walk-
ing ability, are substantially reduced early after THA2–5; this is 
why postoperative rehabilitation is offered throughout the 
municipalities in Denmark. In some municipalities, this is organ-
ized as outpatient supervised rehabilitation, whereas in other 
municipalities, patients receive an initial instruction and perform 
rehabilitation exercise in their own homes without supervi-
sion. In Central Denmark Region (place of this trial), the current 
predominant clinical practice is home-based rehabilitation for 
most patients.
Systematic reviews with meta-analyses show that supervised, 
outpatient rehabilitation exercise is not superior to home-
based exercise for performance-based or self-reported function 
outcomes6,7. It has also been difficult to demonstrate clear supe-
riority with relevant effect size of one type of rehabilitation exer-
cise over another for performance-based or self-reported function 
outcomes8,9. There is, however, some evidence to indicate that 
rehabilitation exercise may be superior to no or very little reha-
bilitation exercise for selected muscle-strength, gait, and function 
outcomes after THA6,9,10. It suggests that a dose-response 
relationship exists for post-operative rehabilitation exercise 
and recovery after THA.
To be able to investigate a dose-response relationship for 
post-operative rehabilitation exercise and recovery after THA, 
objective measures that capture compliance to home-based 
exercise are needed11. In recent work12–14, we have validated a 
measure to monitor compliance to home-based exercise in 
healthy subjects (an in-built sensor attached to an elastic exercise 
band), and started using it in clinical populations for interven-
tion research15–18. With the PHETHAS-1 trial, we want to use 
this sensor technology to investigate if a dose-response relation-
ship exists for home-based rehabilitation exercise and recovery 
after THA, using a prospective cohort study design. By using 
this technology, we will be able to not only investigate a dose-
response relationship on the recovery associated with exercise, 
but also investigate the preliminary efficacy of home based, reha-
bilitation exercise after THA. This can be achieved by compar-
ing participants with the least exercise compliance to those with 
the most. This will indicate whether home-based, rehabilita-
tion exercise “works” better than no or very little rehabilitation 
exercise, although not a randomized comparison. It will help 
inform a subsequent large-scale, confirmatory, randomized trial 
investigating the efficacy of rehabilitation exercise after THA 
when compared to no or very minimal rehabilitation exercise.
Objectives
The primary objective is to indicate the preliminary efficacy 
of home-based rehabilitation using elastic band exercise on 
performance-based function after THA, based on the 
relationship between the performed exercise dose and the 
change in performance-based function (gait speed measured by 
40-m fast-paced walk test) from 3 (start of intervention) to 
10 weeks (end of intervention) after surgery.
The secondary objective is to investigate if a dose-response 
relationship exists between the performed exercise dose and 
changes in: hip-related disability, lower-extremity functional 
performance, and hip muscle strength.
Methods
Study design
The study is a pragmatic, single-center, prospective cohort study 
(single cohort) conducted in Silkeborg, Denmark. By pragmatic 
study we mean that the study reflects real life for the involved 
trial stakeholders. In this study this is for instance reflected by 
the type and dose of exercise which reflects our current practice. 
Outcome assessments will be performed at 3 (start of home- 
based strengthening exercise) and 10 weeks (after 7 weeks 
of home-based strengthening exercise) after surgery. Further-
more, patient-reported outcome measures will be collected pre- 
surgery (see the participant timeline in Table 1). It is the aim 
that all outcome assessments will be performed by three physi-
otherapists who have been thoroughly trained in performing 
the outcome assessments. The data collection methods, trial 
logistics and the intervention have been tested in a pilot study 
including 10 patients and adjustments have been made accord-
ingly. The study will adhere methodologically to the STROBE 
guideline for prospective cohort studies and the CONSORT 
statement.
Study setting
All participants will be included from the Elective Surgery Cen-
tre at the public hospital, Silkeborg Regional Hospital. Exer-
cise instruction as well as blinded outcome assessments will be 
performed by physiotherapists from Elective Surgery Centre. 
The physiotherapists are members of the staff of physiothera-
pists at Elective Surgery Centre and all have at least 6 months 
of experience working with THA.
Participants
Participants will be included by consecutive sampling. The 
inclusion criteria are: age above 18 years, scheduled for a pri-
mary THA at the Elective Surgery Centre due to osteoarthritis 
and able to understand written and spoken Danish. The exclu-
sion criterion is: referral to supervised rehabilitation in 
1 Abbreviations: ADL, Activities of Daily Living; CI, Confidence Interval; 
HOOS, Hip disability and Osteoarthritis Outcome Score, ICMJE, International 
Committee of Medical Journal Editors; IQR, Inter Quartile Range; NRS, 
Numeric Rating Scale; THA, Total Hip Arthroplasty; PHETHAS, Pragmatic 
Home-Based Exercise after Total Hip Arthroplasty – Silkeborg; RM, Repetition 
Maximum; STROBE, STrengthening the Reporting of OBservational studies in 
Epidemiology; TIDieR, Template for Intervention Description and Replication; 
TUT, time-under-tension; VAS, Visual Analogue Scale; WHO, World Health 
Organisation
            Amendments from Version 1
All 3 reviewers approved the original manuscript, thus there are 
no major changes in the new version of the manuscript. The 
changes concern primarily elaboration of the argumentation for 
the chosen exercise intervention and definitions of some key 
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the municipality (instead of the home-based rehabilitation 
exercise-program in the present study).
Intervention
We define rehabilitation exercise as: “A regimen or plan of physi-
cal activities designed and prescribed for specific therapeutic 
goals. Its purpose is to restore normal musculoskeletal func-
tion or to reduce pain caused by diseases or injuries.” The exer-
cise intervention in the present study reflects the standard reha-
bilitation exercise practice at Elective Surgery Centre; hence, a 
pragmatic approach is used. The exercises in the present trial are 
comparable to the control intervention in a previous study 
from our department where we compared usual care (home-
based exercise using elastic band resistance) to supervised 
progressive resistance training in machines and found com-
parable effects19. During a short hospital stay (typically 
discharge on the day after surgery), all patients are instructed 
in an exercise program of unloaded exercises (not part of the 
intervention studied) to be performed at home during the initial 
3 postoperative weeks until their scheduled follow up visit at 
the hospital. At this visit (3 weeks after surgery), and after the 
outcome assessment, the participants will receive a thorough 
instruction in the strengthening exercises that they are instructed 
to perform without supervision in their own homes the fol-
lowing 7 weeks. The instruction is conducted one-to-one by 
physiotherapists using approximately 20 minutes per partici-
pant and supported by an instruction booklet with written and 
illustrated exercise descriptions. The strengthening exercises 
included are: hip abduction, flexion and extension with elas-
tic band resistance and sit-to-stand. The prescribed training load 
will be two sets with repetitions to contraction failure (neu-
romuscular fatigue) and a relative load of 10 to 20 repetition 
maximum (RM), performed every second day (3–4 times a 
week). The strengthening exercises are supplemented with daily 
stretching of hip flexor muscles and balance exercise (one- 
legged stance). Exercise compliance for the strengthening exer-
cises will be monitored objectively (see Outcomes section). No 
efforts will be made to increase compliance beyond normal prac-
tice (e.g. SMS encouragements, or likewise), because we intent 
to measure actual, uninfluenced compliance as close to daily 
practice as possible. The patients are recommended to per-












Eligibility screen X (pre)
Informed consent X (pre)
Interventions
Unloaded exercise X (post) →
Strengthening exercise Exercise instruction X
Assessments
Elastic band sensor (BandCizer) X
40-m fast-paced walk test X X
HOOS* X (pre) X X
30-s chair stand test X X
Hip muscle strength X X
Pain: VAS** at rest before + after exercise X
Self-reported additional exercises X
Self-efficacy X (pre) X
Physical activity (ActivPal) X (7 days data collection)
Adverse events X X
Motivation to exercise as prescribed X
Evaluation of prescribed exercises X
Change in hip problems X
Perception of result after surgery X
* HOOS: Hip disability and Osteoarthritis Outcome Score
** VAS: Visual Analogue Scale
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rehabilitation. They are advised to gradually increase their 
general activity level after the operation to comply with the rec-
ommendations on physical activity from the Danish Health 
and Medicines Authority (≥30 minutes/day of physical activ-
ity with moderate intensity + 20 minutes twice a week of physi-
cal activity with high intensity). Furthermore, they will be 
given instructions on how to handle pain during exercises and 
recreational activities (the pain management guide is available as 
Extended data)20. To reinforce similar treatment administration, 
face-to-face meetings among the participating physiothera-
pists will be held per need to discuss issues experienced in the 
clinic. The exercise intervention is described in detail accord-
ing to the exercise-specific Consensus on Exercise Reporting 
Template (CERT)21 (A completed CERT checklist is available as 
Extended data)20, supplemented with the full set of strength train-
ing descriptors as suggested by Toigo and Boutellier (Table 2)22. 
Finally, the exercise intervention is described according to the 
Template for Intervention Description and Replication (TIDieR) 
checklist, which is a generic intervention-description template 
(a completed TIDieR checklist is available as Extended data)20,23.
Patient information
The participants will be advised to gradually increase their activ-
ity level after the operation. Likewise, they will be instructed 
to gradually progress their exercises during the 7 weeks of train-
ing at home according to the described progression model, where 
the strengthening exercises are performed to failure in each set; 
when the possible repetitions exceed 20 in two of the three elas-
tic band exercises they should change the elastic band so that a 
higher loading is possible. The participants are instructed that 
pain in relation to exercise is normal, and that up to 5 on a numeric 
rating scale (NRS) during exercise is considered acceptable 
based on the suggested pain monitoring system by Thomée 
et al.24. However, the pain should decrease within 30 minutes 
after the exercise session. The participants are advised to con-
tact the hospital if they experience increasing pain or other 
complications such as swelling or wound problems (the 
pain management guide is available as Extended data)20.
Outcomes
Exposure. Performed exercise dose will be quantified as the total 
physiological exercise stimulus (Time under tension summary 
dose per week) recorded by a sensor (Bandcizer: commercially 
available from www.bandcizer.com) attached to the elastic exer-
cise band. The sensor automatically switches on and stores data 
when the elastic exercise band is used13,14. Furthermore, per-
formed exercise dose will be quantified as the number of days 
with strengthening exercises being performed.
Primary outcome
Change in gait speed is chosen to be primary outcome, as walk-
ing ability is considered the most important function to improve 
by patients undergoing THA surgery25. Furthermore, the 
40-m fast-paced walk test is part of the core set of functional 
tests to include in clinical trials in patients with osteoarthritis 
in hip or knee recommended by OARSI26,27.
• Change in gait speed
 Measured by the 40-m fast-paced walk test26,27. 
Change from 3 to 10 weeks after surgery.
Secondary outcomes
• Gait speed
 Measured by the 40-m fast-paced walk test26,27. 
At 10 weeks after surgery.
• Change in patient-reported function
 Measured by the Activities of Daily Living 
(ADL) subscale of HOOS28. HOOS is a dis-
ease-specific patient-reported outcome mea-
sure. Change from 3 to 10 weeks after surgery.
• Change in patient-reported symptoms
 Measured by the symptoms subscale of 
HOOS28. Change from 3 to 10 weeks after 
surgery.
• Change in patient-reported pain
 Measured by the pain subscale of HOOS28. 
Change from 3 to 10 weeks after surgery.
• Change in patient-reported hip related quality of life
 Measured by the quality of life subscale of 
HOOS28. Change from 3 to 10 weeks after 
surgery.
• Change in lower extremity function.
 Measured by the 30-s chair stand test26,27 (The 
maximal number of rises from a chair within 
30 seconds). Change from 3 to 10 weeks after 
surgery.
• Change in hip abductor muscle strength.
 Test of isometric muscle strength in hip 
abduction in the operated leg. The hand-held 
dynamometer Power Track II Commander 
will be used to assess this using standardized 
test procedure29. Change from 3 to 10 weeks 
after surgery.
• Change in hip flexor muscle strength.
 Test of isometric muscle strength in hip flexion 
in the operated leg. The hand-held dynamom-
eter Power Track II Commander will be used to 
assess this using standardized test procedure29. 
Change from 3 to 10 weeks after surgery.
Other pre-specified outcomes
• Self-efficacy.
 The general self-efficacy scale30 will be used 
to measure self-efficacy, defined as an indi-
vidual’s belief in his or her capacity to exe-
cute behaviors necessary to produce specific 
performance attainments. At 3 weeks after 
surgery.
• 24-hour physical activity (mean upright time/day and 
mean number of steps/day).
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 An ActivPAL movement-sensor will be used 
to measure mean time per day in upright 
position (standing and walking) based on 
7 days of data collection. The sensor will be 
applied 3 weeks after surgery and used the 
following week. At 4 weeks after surgery.
• Number of participants with adverse events.
Number and type of adverse events will be registered 
by the physiotherapist 3 and 10 weeks after surgery in 
the following pre-defined categories: Hip dislocation, 
infection, fracture, wound seepage, acute myocardial 
infarction, deep venous thrombosis, readmission 
and other.
• Mean change in pain after each exercise session.
 The visual analogue scale (VAS) will be used 
to assess pain before and after each exercise 
session. Data will be summarized as a mean 
change in pain per exercise session for the 
entire intervention period. At 10 weeks after 
surgery.
• Number of pain flares after exercise sessions.
 VAS will be used to assess pain before and 
after each exercise session. Pain flare is defined 
as an increase in pain of ≥20 mm31. Data 
will be summarized, both for the first 14 
days of the intervention and for the entire 
intervention period. At 5 and 10 weeks after 
surgery.
• Motivation to perform the prescribed exercises.
The participants will be asked about their motivation to 
perform the prescribed exercises. A short questionnaire 
comprising three questions developed for this purpose 
will be used (the questionnaire is available as Extended 
data)20. The possible responses are ordered in 4 levels of 
motivation on an ordinal scale. At 3 weeks after surgery.
• Evaluation of the prescribed exercises
The participants will be asked to evaluate the exer-
cises. A short questionnaire comprising three questions 
developed for this purpose will be used (the question-
naire is available as Extended data)20. The possible 
responses are ordered in 4 levels on an ordinal scale. 
At 10 weeks after surgery.
Changes to outcomes after trial registration
• At June 28, 2017, two outcome measures were added 
to the study. At 10 weeks after surgery, participants 
will be asked both to describe their perception of the 
result after surgery and the change in hip problems 
(from preoperatively to 10 weeks after surgery). The 
questions will be phrased as "How would you describe 
the result of your operation?" with response catego-
ries "Excellent", "Very good", "Good", "Fair", "Poor". 
The second question will be asked as "Overall, how 
are the problems now in the hip on which you had 
surgery, compared to before your operation?" with the 
response categories "Much better", "A little better", 
"About the same", "A little worse", "Much worse". 
These two questions have been used as anchor questions 
to establish patient acceptable symptom state (PASS) 
and minimal clinically important improvement (MCII) 
cut-points for patient-reported outcomes – including 
some subscales of HOOS – 1 year after THA32. We will 
use these questions to group patients according to their 
perception of result of the operation and changes in hip 
problems, as well as for exploratory analysis of PASS 
and MCII cut-points for HOOS, 10 weeks after surgery.
• In April, 2019, pain flare was added as an outcome 
measure.
• Categories of adverse events were defined prior to 
study start, but they were not specifically described in 
the trial registration. Motivation to perform prescribed 
exercises was registered as outcome, but although 
predefined, the three items in the short question-
naire were not specifically described. Evaluation of 
prescribed exercises was added as outcome prior to study 
start.
• In April 2019, the secondary objective was added to 
the primary and pre-specified objective because the 
primary objective did not clearly outline the secondary 
analyses of secondary outcomes for the hypothesized 
dose-response relationship.
• All the changes outlined above occurred before the last 
participant was included and the study was unblinded 
(please see “Blinding” below).
Embedded qualitative study (PHETHAS-2)
In addition to collecting quantitative data, we will also con-
duct an embedded qualitative study concerning the participants’ 
experience with performing home-based exercise and resum-
ing general physical activities. The aim will be to understand 
the patients’ motivation and barriers related to home-based exer-
cise and general physical activity after THA. The participants 
will be selected through theoretical sampling33, expectedly a 
maximum of 20. Participants will be recruited partly from the 
PHETHAS-1 trial, and partly from the population of standard 
THA patients not involved in an exercise trial. This is done to 
elucidate the influence of participating in a trial with extra inter-
ventions such as exercise diary, outcome assessments, etc. 
Semi-structured interviews will be conducted 10 weeks postop-
eratively using an interview guide (available as Extended data)20. 
This qualitative study is undertaken to refine the home-based 
intervention for future trials and clinical implementation. 
The embedded qualitative study will be reported in a separate 
paper with a clear reference to the PHETHAS-1 trial.
Sample size
The sample size estimation is based on a minimal clinical impor-
tant difference of 0.2 m/sec34 between changes in gait speed 
among participants with highest performed exercise dose com-
pared to participants with smallest performed exercise dose. Based 
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on results from a pilot study leading up to this trial, we expect 
a maximal difference of 4 hours in performed exercise dose (total 
Time under tension summary dose) during the 7-week inter-
vention period between participants with highest and lowest 
exercise compliance. Also based on the pilot study, a SD of 1.06 
hours for exercise dose and 0.16 m/sec for change in gait speed 
were used. The power is set at 0.90 to increase the power for 
secondary analyses, and with a 0.05 level of significance. Based 
on the above, the required sample size is estimated to be 
88 participants.
Recruitment
The basis for recruitment makes the trial highly feasible due 
to the approximately 800 elective THA procedures performed 
annually at the Elective Surgery Centre. As there may be more 
eligible participants per day than for whom there is available 
equipment (BandCizers and ActivPAL sensors), we restrict inclu-
sion by including consecutive participants from random sections 
of the department. That is, patients examined and booked for 
surgery in pre-specified clinics in the outpatient department. 
Patients are allocated to the specific clinics in the department 
by a secretary at random and with no influence from any per-
sonnel involved in the study. The estimated inclusion rate is 
approximately one to two participants per week; please 
see estimated participant flow and current recruitment status 
in Figure 1.
Blinding
The outcome assessors will be blinded to exercise compliance- 
data. Moreover, we will inform the participants that we 
Figure 1. Estimated participant flow. 
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measure how they perform their exercises and not how much they 
exercise or what the study hypothesis is. This is done with the 
purpose of minimizing sensor-induced influence on compliance 
and to reduce expectation bias.
Data collection methods
The elastic band sensor (BandCizer) automatically records and 
stores exercise data during elastic band exercises. It is a valid 
measure of date, time of day, number of repetitions and sets, 
total time-under-tension (TUT), and total single repetition TUT 
during commonly used home-based strength training exer-
cises for the lower extremities14. The 40-m fast-paced walk test 
measures performance-based function and is part of the recom-
mended core set of tests to assess physical function in people 
diagnosed with hip or knee osteoarthritis by the Osteoarthri-
tis Research Society International (OARSI)26,27. A high inter-
tester reliability is shown (intraclass correlation coefficient 
(ICC) 0.95) in a population with hip osteoarthritis34. The HOOS 
questionnaire measures patient-reported outcome in the sub-
scales: symptoms, pain, ADL, function in sport and recrea-
tion and hip-related quality of life28. HOOS is shown valid, 
responsible, and reliable (ICC >0.78) when evaluating patients 
undergoing THA35. Hip muscle strength29 and 30-s chair stand 
test will be conducted in accordance with previous published 
methods27,29 showing acceptable relative and absolute inter-rater 
reliability when used after THA (ICC 0.83-0.93 and SEM 
7–10%)36. General Self-Efficacy Scale is a 10-item validated 
questionnaire holding a scale assessing optimistic self-beliefs 
to cope with a variety of difficult demands in life, scored 
between 1–4 points without any defined cut-off point30. ActivPal 
movement-sensors measures physical activity as time spent in the 
sit/lie position (X-axis), standing (Y-axis) and walking (Z-axis). 
It has been validated in several studies in healthy adults37 and 
in older adults with a hip fracture38,39.
Data collection will continue for participants who discon-
tinue their training. Data collection will only be discontinued if 
participants explicitly withdraw from the study or any major 
events or diseases prevent the outcome assessments. If par-
ticipants do not attend their scheduled follow ups, they will be 
contacted and offered a new time.
Data management
Raw data from the Bandcizer will be uploaded to a secure 
online database using a tablet or smartphone. Here, the inves-
tigator will be able to access and analyze data and extract the 
following variables; date and number of training sessions, 
number of repetitions, time under tension for each repetition and 
total time under tension for each training session. Data from the 
outcome measurement will be double entered in EpiData 3.1 
using anonymous coding with ID numbers and relevant range 
checks for data values to minimize typing errors. Completed 
data collection forms will be stored in a locked cabinet at 
Silkeborg Regional Hospital. Electronic data files will be stored 
on a secured hospital server with access requiring personal login. 
The linkage between ID numbers and personal identification 
data (e.g. civil registration number, name, address) will be stored 
as an electronic file as described above.
Statistical methods
All the planned analyses are listed in Table 3.
Descriptive analyses will be performed for demographic vari-
ables, supplementary descriptive variables, adverse events, 
motivation to perform prescribed exercises, evaluation of pre-
scribed exercises and pain after exercise sessions (change in 
pain and pain flares). Data will be presented as means with 95% 
confidence intervals (CI) or medians with inter quartile 
ranges (IQR) for continues variables and as frequencies with 
percentages for categorical variables.
Primary analysis
Initially, scatterplots of outcome variables and exercise dose 
variables will be used to suggest starting model structures 
and possible more complex alternatives. The structures of the 
models used for the dose-response analysis will depend on the 
specific relationship between change in gait speed and the exer-
cise dose variable. Because of this, and not having any prior 
knowledge of the structure of the relationship, multiple models 
will be fitted and evaluated by R-squared values to identify the 
models that fit data the best. As a starting point, the first model 
will be fitted as a fixed increase in outcome, based on exer-
cise dose-change done by linear regression modelling. If neces-
sary, more complex regression such as polynomial relationship 
and other nonlinear structures will also be evaluated.
In the case that none of the models seem to fit the data, a linear 
regression model with a categorical variable based on inter-
vals of the exercise dose variable will be fitted. This model does 
not provide a direct dose response relationship but provides an 
estimate of the association between the outcome variable and 
the exercise dose variable within the specific intervals.
“Regression to the mean” may be present and will be evaluated 
by the correlation between the change and the measure at base-
line. If regression to the mean is believed to be present for an 
outcome, the models of the outcome will additional include 
the baseline measure to adjust for regression to the mean.
Possible confounding variables (self-efficacy (baseline), physi-
cal activity (during intervention), and gait speed (baseline)) 
will also be included in the models. The confounding effect of 
each variable will be examined by comparison of dose response 
estimates in models with and without the confounder. If there 
is no relevant change between the estimates of the models, 
the confounder will be excluded from the model. Normality 
assumptions in the models are evaluated by QQ-plots
Secondary analyses
For the dose response relationship between change in HOOS 
ADL, the analysis will be similar to the analysis for change 
in gait speed outlined above.
The relationship between exercise compliance and HOOS 
subscales (symptoms, pain, quality of life), 30-s chair stand test 
and hip muscle strength will be presented as means with CIs 
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3) If 1) and 2) is not possible, we will use the total number 
of days with performed exercise as an estimate of the total 
exercise dose.
We will report the proportion of missing data, e.g. self-reported 
non-compliance in Bandcizer use or invalid Bandcizer sensor- 
data. Furthermore, we will perform a sensitivity analysis 
using data on total exercise dose (days with exercise) from 
the exercise diary. This will inform if there is a comparable 
dose-response relationship when analyzing self-reported compli-
ance data compared to objectively measured data (Bandcizer). 
The two types of data yield a risk of different types of bias. 
Self-reported exercise dose is often over-estimated and the 
Bandcizer data may induce problems with missing data as 
described above which could led to an underestimation of 
exercise-dose.
Missing items within the HOOS and General Self-efficacy 
scale will be handled as recommended in the guidelines 
(HOOS: <50% missing items in each subscale is accepted, 
self-efficacy: ≤3 missing items is accepted). Concerning 
ActivPal data, a minimum of four days of data collection will 
be accepted as sufficient to calculate min/day upright time and 
steps/day41. In situations where participants have to stop the 
physical tests due to pain, the data from the best performance 
are used no matter if the pre-defined number of repetitions is 
reached. It is noted if tests are interrupted due to pain to be 
able to perform sensitivity analysis if appropriate. If partici-
pants are lost to follow up (despite the before-mentioned efforts 
to keep every participant in the trial) they will be excluded 
from the analyses that include change scores. We will not use 
last-observation-carried-forward or other imputation procedures 
on exposure (exercise dose), as we aim to investigate relation-
ships between actually performed exercise dose and changes 
in post-operative outcomes. However, on possible confounding 
variables that are included in the model, we will use multi-
ple imputation if needed to retain the sample size of n=88 in 
the analysis. Models used in the imputation will include the 
remaining confounders with measures as predictors.
Data monitoring
Since the study involves no major changes to current prac-
tice it is not deemed necessary to establish a data monitoring 
committee or perform any interim analyses. Likewise, no 
provisions for post-trail care will be made.
Discussion
This trial will add knowledge concerning the preliminary effi-
cacy of home-based rehabilitation using elastic band exercises 
based on the relationship between performed exercise dose and 
outcomes after THA. We believe this is the first trial to do so, 
since earlier attempts have not used objective measurement of 
exercise dose as in the present trial. In an observational cohort 
study, Zech et al. found no significant associations between 
the exercise therapy intensity or duration and improve-
ments in patient reported function, pain, and stiffness42. How-
ever, the exercise dose was dependent on the participants´ 
health insurance as well as individual conditions and the 
or medians with IQRs within each of the compliance quartiles, 
as well as graphical representation of these values.
Exploratory analyses
To better understand what may relate to how patients comply 
with prescribed rehabilitation exercise after THA, we will inves-
tigate how different variables relate to exercise compliance 
(dependent variables: time under tension summary dose and 
total number of exercise sessions), using uni-variable modelling. 
Independent variables will be: pain flares (first two weeks of 
intervention), pain flares (entire intervention period), HOOS 
pain (baseline), motivation to perform exercises, belief in effect 
of exercises, self-belief in compliance to exercising, satisfaction 
with rehabilitation exercise, physical activity (mean upright 
time/day and mean number of steps/day) and self-efficacy 
(baseline).
To better understand what may relate to how physically active 
patients are after a THA, we will investigate how differ-
ent variables relate to physical activity (dependent variables: 
mean upright time/day and mean number of steps/day), using 
univariate modelling. Independent variables will be: pain 
flares (first two weeks of intervention), HOOS pain (baseline), 
motivation to perform exercises, self-belief in compliance to 
exercising, and self-efficacy (baseline).
In the analysis of “result of the operation”, the change in 
score from baseline to follow-up will be presented for each 
HOOS subscale (pain, symptoms, ADL, QOL) and gait speed. 
Data will be presented both for each response category of the 
anchor question, and for the subgroup of patients, who answered 
“excellent”, “very good” or “good” data. This subgroup is consid-
ered to be reporting a hip-specific acceptable symptom state. Data 
will be presented by means with 95% CI or medians and inter-
quartile ranges (IQR). In each response category of the question 
for “change in hip problems”, the change in score from baseline 
to follow-up will be presented for each HOOS subscale (pain, 
symptoms, ADL, QOL) and gait speed. Data will be presented 
by mean scores with 95% CI or median and inter quartile 
range (IQR).
Furthermore, for each exercise dose quartile, the percentage of 
patients in each response category of the questions for “result 
of the operation” and “change in hip problems”, will be pre-
sented graphically. Finally, HOOS cut points for PASS and 
MCII will be estimated by the mean score or mean change 
approach40.
Handling of missing data
Based on the importance of the Bandcizer data, we have 
planned for how to use the data if we are not able to extract it 
as planned. Thus, we prioritize to use the Bandcizer data the 
following way depending on what is possible:
1) As planned with a valid total time-under-tension (TUT) 
estimate. 
2) If 1) is not possible, we will use the total number of 
repetitions as an estimate of the total exercise dose.
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physiotherapist’s decision, which likely induces a risk of bias by 
indication.
The essential need from a clinical perspective is to be able to 
prescribe evidence-based exercise programs after THA. Despite 
the growing number of studies, a recent systematic review 
that included 20 studies concludes that insufficient therapeu-
tic validity and potentially high risk of bias in the included 
studies limit the ability to assess the effectiveness of exercise 
after THA43.
The new knowledge from the present study can potentially 
identify whether the dose of performed home-based exercise 
is related to changes in post-operative outcomes after THA. It 
will give insight concerning the potential influence from other 
factors than exercise, such as general physical activity and self- 
efficacy. Furthermore, the embedded qualitative study will 
give insight to perceived motivation and barriers to perform 
the prescribed exercise as well as to resuming general physical 
activities. The results from both the quantitative and quali-
tative study are expected to be useful in optimizing current 
practice; however, the results will also be used to plan, power 
and execute a randomized controlled trial that compares the 
effectiveness of rehabilitation exercises to no rehabilitation 
exercises (just resuming general physical activities).
Strength and limitations
The strengths of this study include the objectively meas-
ured exercise dose, the standardized and thoroughly described 
intervention and the inclusion of outcome variables at all levels 
in the International Classification of Function, Disability and 
Health (ICF). We chose gait speed measured by the 40-m fast-
paced walk test as the primary outcome. Walking ability is 
considered the most important function to improve by patients 
undergoing THA surgery25, and the 40-m fast-paced walk test 
is part of the core set of functional tests to include in clinical 
trials in patients with osteoarthritis in hip or knee recommended 
by OARSI26. An important candidate for the choice of primary 
outcome for clinical research has been suggested to be a patient-
reported one44. Nevertheless, we chose a performance-based 
measure as the primary, as we were concerned about ceiling 
effects on patient reported outcomes that measures function and 
pain, such as the HOOS questionnaire after THA45.
Multiple factors can potentially affect exercise compliance; 
therefore, we include measurements of physical activity and 
self-efficacy. Also, it is not known which outcomes that is most 
susceptible to exercise dose which is why we include a broad 
range of different outcome types to be able to explore potential 
dose-response relationships.
Blinding of participants in randomized exercise trials are often 
impossible, in the present study we seek to blind the partici-
pants to the specific focus om exercise dose, they are just told 
that we measure “the way they exercise”. Hypothesis blinding is 
considered a design strength when blinding of participants 
regarding treatment is not possible46. Furthermore, we blind the 
outcome assessor in the sense that they are not allowed to see the 
exercise diary or BandCizer data prior to the outcome assessment.
Trial status
The trial began recruiting participants in April 2017. After a 
period with slow inclusion, the inclusion rate is back at 1–2 
participants per week, thus, inclusion is expected to be completed 
in July 2019. See current status on participant flow in Figure 1.
This paper is based on protocol version 5, March 8, 2019.
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The Ethics Committee of Central Denmark Region accepted ini-
tiation of the study and reviewed the study as non-notifiable 
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Informed consent
Trained Research staff (nurse or physiotherapist) will provide 
presentation of comprehensible information about the research 
to potential participants, confirmation that they understand 
the research, and assurance that their agreement to partici-
pate is voluntary. Potential participants will also receive infor-
mation sheets. They will be offered deliberation time and, 
subsequently, written consent will be obtained from those 
who choose to participate. The informed consent document is 
available as Extended data20.
Confidentiality
All records that contain names or other personal identifiers, such 
as informed consent forms, will be stored separately from study 
records identified by code number to protect confidentiality before, 
during, and after the trial.
Future availability of trial data
The principal investigator, as well as all co-authors, will have 
access to the full dataset as needed. A fully anonymized dataset 
and statistical analysis code will be made available for the scien-
tific journal reviewing the manuscript within six months in line 
with the recent proposal from the International Committee 
of Medical Journal Editors (ICMJE)47.
Dissemination policy
Results from the trial will be published in international, 
scientific peer-reviewed journals, no matter the trial outcome. 
The results will also be presented at relevant scientific confer-
ences and symposiums. Authorships will be allocated accord-
ing to the ICMJE recommendations. The following papers are 
planned:
1. Pragmatic Home-Based Exercise after Total Hip 
Arthroplasty – Silkeborg (PHETHAS-1): Results from a 
prospective cohort study.
2. Motivation and barriers to perform home-based exercise 
after Total Hip Arthroplasty – a qualitative embedded 
study within the PHETHAS-1 trial.
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